<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-type="olc" bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public" slc-id="S1-TAM21052-MS7-46-SPG"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 S166 IS: Emergency Support for Substance Use Disorders Act</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2021-02-02</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">II</distribution-code><congress>117th CONGRESS</congress><session>1st Session</session><legis-num>S. 166</legis-num><current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber><action><action-date date="20210202">February 2, 2021</action-date><action-desc><sponsor name-id="S394">Ms. Smith</sponsor> (for herself and <cosponsor name-id="S288">Ms. Murkowski</cosponsor>) introduced the following bill; which was read twice and referred to the <committee-name committee-id="SSHR00">Committee on Health, Education, Labor, and Pensions</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title>To authorize grants to address substance use during COVID–19.</official-title></form><legis-body style="OLC" display-enacting-clause="yes-display-enacting-clause" id="HB111FBDD78DA4DD4ACC23751F44A134D"><section section-type="section-one" id="H2733EAD8CE3044DBB3B4359D3AC63633"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Emergency Support for Substance Use Disorders Act</short-title></quote>.</text></section><section section-type="subsequent-section" id="idCE54B73EE56148FF91C37C28F81B3BEB"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">Congress finds the following:</text><paragraph id="HFD70F6256199436FB612B0DEED7DC0D2"><enum>(1)</enum><text>In 2018, an estimated 164,800,000 people aged 12 or older in the United States, or 60.2 percent of such population, were substance users (including, tobacco, alcohol, or illicit drugs) in the last month.</text></paragraph><paragraph id="H0E1ADEF1E75F4EAD93A3FBC73F3F7139"><enum>(2)</enum><text>In 2018, nearly 1 in 5 people aged 12 or older in the United States, or 19.4 percent of such population, used an illicit drug in the past year, which is a higher percentage than in 2015 and 2016.</text></paragraph><paragraph id="HAC1E453C963F452A8CE3BEAB146C7A47"><enum>(3)</enum><text display-inline="yes-display-inline">In 2018, an estimated 10,300,000 people aged 12 or older in the United States misused opioids in the past year, including 9,900,000 prescription pain reliever misusers and 808,000 heroin users.</text></paragraph><paragraph id="H70EFE8D06EB94B48991A8B1E918F5369"><enum>(4)</enum><text display-inline="yes-display-inline">In 2017, overdose deaths involving opioids in the United States, including fentanyl, was 6 times higher than in 1999.</text></paragraph><paragraph id="H13163DD0EBD040B19ABE0A44BB7D4D45"><enum>(5)</enum><text display-inline="yes-display-inline">The age-adjusted rate of drug overdose deaths involving synthetic opioids in the United States other than methadone increased by 10 percent from 2017 to 2018.</text></paragraph><paragraph id="HFE94301DE83F4EE7BE8563F31B5C3E46"><enum>(6)</enum><text display-inline="yes-display-inline">In 2018, approximately 20,300,000 people aged 12 or older in the United States had a substance use disorder related to their use of alcohol or illicit drugs in the past year.</text></paragraph><paragraph id="H47F91BC9DC3A4D5B89DD5CE9158E84AD"><enum>(7)</enum><text display-inline="yes-display-inline">In 2018, an estimated 21,200,000 people aged 12 or older in the United States needed substance use treatment.</text></paragraph><paragraph id="H7778207733204BB4913490D6ACF45825"><enum>(8)</enum><text display-inline="yes-display-inline">According to the Substance Abuse and Mental Health Services Administration, COVID–19 will certainly contribute to growth in the numbers referred to in the preceding paragraphs. Individuals across the United States will struggle with increases in depression, anxiety, trauma, and grief. There is also anticipated increase in substance misuse in the United States as lives are impacted for individuals and families.</text></paragraph></section><section id="HE2FB66B75E6940239569C279343B5F43"><enum>3.</enum><header>Grant program on harms of drug misuse</header><subsection id="idd067465756ea445b92da4f86783e8a76"><enum>(a)</enum><header>In general</header><text>The Assistant Secretary for Mental Health and Substance Use (referred to in this section as the <quote>Assistant Secretary</quote>), in consultation with the Director of the Centers for Disease Control and Prevention, shall award grants to States, political subdivisions of States, Tribes, Tribal organizations, and community-based entities to support the delivery of overdose prevention, syringe services programs, and other harm reduction services that address the harms of drug misuse during the COVID–19 pandemic, including by—</text><paragraph id="id147dfeb5d01e497393fd3477b97c1125"><enum>(1)</enum><text>preventing and controlling the spread of infectious diseases, such as HIV/AIDS and viral hepatitis, and the consequences of such diseases for individuals with substance use disorder;</text></paragraph><paragraph id="idf8751779a348468dbf4dce049d87636e"><enum>(2)</enum><text>distributing opioid antagonists, such as naloxone, to individuals at risk of overdose;</text></paragraph><paragraph id="id5e6d69b41c1140ad8387ff4736d64862"><enum>(3)</enum><text>connecting individuals at risk for, or with, a substance use disorder to overdose education, counseling, and health education; and</text></paragraph><paragraph id="idb4ee4e6e03a54f9290d7203a1f6883f3"><enum>(4)</enum><text>encouraging such individuals to take steps to reduce the negative personal and public health impacts of substance use or misuse during the emergency period.</text></paragraph></subsection><subsection id="id56c4e4b87200494aa357f2c519c6a6ff"><enum>(b)</enum><header>Considerations</header><text>In awarding grants under this section, the Assistant Secretary shall prioritize grants to applicants that are—</text><paragraph id="idB7A90D30DF894053A63C66B93BFC4705"><enum>(1)</enum><text>culturally specific organizations, Tribal behavioral health and substance use disorder providers, or organizations that are intentional about serving populations where COVID–19 has had the most impact; or </text></paragraph><paragraph id="id3446FB9148174CA49E0DE277573655A1"><enum>(2)</enum><text>proposing to serve areas with—</text><subparagraph id="idbd08a332d82a41049792c9af39d19b7f"><enum>(A)</enum><text>a higher proportion of the population who meet criteria for dependence on, or abuse of, illicit drugs;</text></subparagraph><subparagraph id="id99eade2918b249cba9e182fabb743605"><enum>(B)</enum><text>a higher drug overdose death rate;</text></subparagraph><subparagraph id="id7681c415e35c4e248db2ea43f6c0846b"><enum>(C)</enum><text>a greater telemedicine infrastructure need; and</text></subparagraph><subparagraph id="id7fe7e49e08014483b04338e0b58776da"><enum>(D)</enum><text>a greater behavioral health and substance use disorder workforce need. </text></subparagraph></paragraph></subsection><subsection id="id2c83c84ee4034ed6812363bfd2ba3543"><enum>(c)</enum><header>Use of grant awards</header><text>A recipient of a grant under this section may use such grant funds for the following purposes:</text><paragraph id="idefd084844b51421ea3af0572f3f0081e"><enum>(1)</enum><text>Adapt, maintain, and expand essential services provided by harm reduction service organizations to address the risks of COVID–19, drug overdose, and contraction of infectious disease.</text></paragraph><paragraph id="id9be174c1ad76473eaf8b964ebff2c602"><enum>(2)</enum><text>Maintain or hire staff.</text></paragraph><paragraph id="id174841fd60394fcf99f0ac32dbc2988d"><enum>(3)</enum><text>Support program operational costs, including staff, rent, and vehicle purchase or maintenance.</text></paragraph><paragraph id="id175be4cf65734fb092f1538e4db1bc6f"><enum>(4)</enum><text>Program supplies.</text></paragraph><paragraph id="ide475ddccea104e969be52662f1176382"><enum>(5)</enum><text>Hygiene and personal protective equipment for both staff and program participants.</text></paragraph><paragraph id="idb76e8c1a87ac433683e9f4f5bc511c7c"><enum>(6)</enum><text>Support and case management services.</text></paragraph></subsection><subsection id="id615ee6814d3c4b4ea9839e8b9ed7b247"><enum>(d)</enum><header>Definition</header><text>In this section, the term <term>emergency period</term> has the meaning given to such term in section 1135(g)(1)(B) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1320b-5">42 U.S.C. 1320b–5(g)(1)(B)</external-xref>).</text></subsection><subsection id="id226e97b658e9404f9c0a227510685457"><enum>(e)</enum><header>Authorization of appropriations</header><text>To carry out this section, there is authorized to be appropriated $50,000,000 for fiscal year 2021, to remain available until expended.</text></subsection></section></legis-body></bill> 

